Article Per Year (5 Year)
p-Index From 2020 - 2025
0.444
P-Index
This Author published in this journals
All Journal International Journal of Cell and Biomedical Science
Sadikin, Nadya Audina N
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Immunology & microbiology Medicine & Pharmacology

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : International Journal of Cell and Biomedical Science

 1 
Effect of Typhonium flagelliforme Extract on the Viability of Colorectal Cancer Cells HCT-116 Sadikin, Nadya Audina N; Nazar, M. Ariq; Ibrahim, Sugeng
International Journal of Cell and Biomedical Science Vol 3 No 7 (2024)
Publisher : Stem Cell and Cancer Research (SCCR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59278/cbs.v3i7.46

Abstract

Background: Colorectal cancer (CRC) remains a significant global health challenge, with rising incidence rates, particularly among younger individuals [1]. Conventional treatments, including chemotherapy and radiation, often cause severe side effects, necessitating the exploration of alternative therapeutic options. Typhonium flagelliforme, a medicinal plant widely used in traditional medicine, has been investigated for its cytotoxic potential against HCT-116 colorectal cancer cells. Objective: This study assessed the cytotoxic effects of T. flagelliforme extract on HCT-116 colorectal cancer cells using the MTT assay. Methods: The cytotoxicity of Typhonium flagelliforme (T. flagelliforme ) extract on HCT-116 colorectal cancer cells was assessed using the MTT assay after 24 hours of treatment with different concentrations (20–100 µg/mL). Results: The findings revealed a dose-dependent reduction in cell viability, with an IC₅₀ value of 73.47 µg/mL, indicating moderate cytotoxic activity. Higher extract concentrations (100–60 µg/mL) significantly decreased cell viability, while the lowest concentration (20 µg/mL) showed a paradoxical increase, possibly due to a hormesis effect. Conclusion: The findings revealed a dose-dependent reduction in cell viability, with an IC₅₀ value of 73.47 µg/mL, indicating moderate cytotoxic activity.
Anticancer effectiveness of Artemisia annua ethanol extract against MDAMB-231 cancer cells Agustina, Rita; Ari, Psn Masruri Sulistiyanto; Sadikin, Nadya Audina N
International Journal of Cell and Biomedical Science Vol 4 No 10 (2025)
Publisher : Stem Cell and Cancer Research (SCCR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59278/cbs.v4i10.68

Abstract

Background: Breast cancer remains one of the leading causes of cancer deaths worldwide, with triple-negative breast cancer (TNBC) posing a significant therapeutic challenge due to its lack of hormonal receptors and resistance to conventional treatment. Artemisia annua L., a medicinal plant traditionally used in Chinese medicine, has received attention for its diverse bioactive compounds, including flavonoids, phenolic acids, and sesquiterpene lactones, which exhibit potential anticancer properties. This study aims to evaluate the in vitro cytotoxic effect of A. annua ethanol extract against MDA-MB-231 human breast cancer cells using the MTT assay. Methods: Extracts were prepared in 10% DMSO and tested at concentrations ranging from 0 to 1000 µg/mL. MDA-MB-231 cells were seeded in 96-well plates and incubated for 24 h before treatment. Post-treatment, cell viability was assessed via MTT assay, and absorbance was measured at 595 nm. The percentage of cytotoxicity was calculated, and the IC₅₀ value was determined through linear regression analysis. Results: The results showed a clear cytotoxic response depending on the dose, with the extract achieving an IC₅₀ value of 56.83 µg·mL-¹ indicating a fairly strong correlation between concentration and cytotoxicity. These findings indicate that A. annua contains bioactive compounds that are able to inhibit cancer cell proliferation. Conclusion: In conclusion, Artemisia annua ethanol extract showed moderate cytotoxic activity against MDA-MB-231 cells, supporting its potential as a complementary therapeutic agent for TNBC. Further studies are needed to elucidate its molecular mechanisms and evaluate its efficacy in vivo.
Co-Authors Agustina, Rita Ari, Psn Masruri Sulistiyanto Ibrahim, Sugeng Nazar, M. Ariq